{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:33:20Z","timestamp":1773419600532,"version":"3.50.1"},"reference-count":59,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["DD\u201020\u20102003"],"award-info":[{"award-number":["DD\u201020\u20102003"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Despite the importance of timely vaccine completion for protection from infectious disease, there is limited knowledge of the immunization adherence rates of children with sickle cell disease (SCD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a retrospective cohort study comparing the immunization rates of children with SCD to those with sickle cell trait between 2008 and 2019 in Georgia. Completion rates for each vaccine and the proportion of children with up\u2010to\u2010date status at 24 and 35 months were calculated and compared between the cohorts. Chi\u2010square tests with odds ratios (OR) for differences and 95% confidence intervals (CIs) were reported on the overall up\u2010to\u2010date rates and rates for individual vaccines at 24 and 35 months for the two cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Children with SCD had higher up\u2010to\u2010date rates than children with sickle cell trait at 24 and 35 months. At 35 months, the overall up\u2010to\u2010date rates (OR\u00a0=\u00a01.17; 95% CI, 1.04\u20101.31;\n                      <jats:italic>p\u00a0<\/jats:italic>\n                      =\u00a0.004) and the four\u2010dose pneumococcal conjugate vaccine series (OR\u00a0=\u00a01.36; 95% CI, 1.18\u20101.57;\n                      <jats:italic>p\u00a0<\/jats:italic>\n                      &lt;\u00a0.001) were significantly different between the groups. Both cohorts had the highest completion rates for the hepatitis B series and the lowest rates for the varicella vaccine. Doses of diphtheria, tetanus, and acellular pertussis vaccine; varicella; and pneumococcal conjugate vaccines were most commonly missed by children in both cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Children with SCD have better immunization coverage than children with sickle cell trait, but there is an opportunity for improvement. Policymakers and healthcare professionals should focus on increasing access to care coordination services among children with SCD to ensure on\u2010time and preventive healthcare services.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pbc.31042","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T02:25:20Z","timestamp":1714789520000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunization adherence among children with sickle cell disease and sickle cell trait: Results of a population\u2010based study"],"prefix":"10.1002","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0808-7046","authenticated-orcid":false,"given":"Jiajing Scarlette","family":"Shi","sequence":"first","affiliation":[{"name":"Georgia Health Policy Center Andrew Young School of Policy Studies Georgia State University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangeetha","family":"Lakshmanan","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center Andrew Young School of Policy Studies Georgia State University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Attell","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center Andrew Young School of Policy Studies Georgia State University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center Andrew Young School of Policy Studies Georgia State University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1573-6734","authenticated-orcid":false,"given":"Amy","family":"Tang","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta  Atlanta Georgia USA"},{"name":"Emory University School of Medicine  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Eckman","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5149-6355","authenticated-orcid":false,"given":"Angela","family":"Snyder","sequence":"additional","affiliation":[{"name":"Georgia Health Policy Center Andrew Young School of Policy Studies Georgia State University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,5,3]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/0033354919881438"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.08.009"},{"key":"e_1_2_9_4_1","unstructured":"Centers for Disease Control and Prevention.What is sickle cell disease? Centers for Disease Control and Prevention. August 18 2022. Accessed September 26 2022.https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/facts.html"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102003\u201011\u20103758"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2009\u20101465"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26713"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182a11808"},{"key":"e_1_2_9_9_1","unstructured":"U.S. Department of Health and Human Services National Institutes of Health.Evidence\u2010based management of sickle cell disease: expert panel report 2014. U.S. Department of Health and Human Services.2014. doi:10.1542\/peds.2014\u20102986"},{"key":"e_1_2_9_10_1","unstructured":"Centers for Disease Control and Prevention.Immunization schedules for 18 and younger. Centers for Disease Control and Prevention. April 27 2023. Accessed July 17 2023.https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child\u2010adolescent.html"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6841e2"},{"key":"e_1_2_9_12_1","article-title":"Vaccine schedules based on medical indication","author":"Centers for Disease Control and Prevention","journal-title":"Centers for Disease Control and Prevention"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/516781"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.12.022"},{"key":"e_1_2_9_15_1","article-title":"Sickle cell trait","author":"Ashorobi D","journal-title":"Treasure Isl FL StatPearls Publ"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018028043"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.12.020"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2021.01.015"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.08.039"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27282"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2018.01.023"},{"issue":"49","key":"e_1_2_9_22_1","first-page":"1155","article-title":"Incidence of sickle cell trait \u2014 United States, 2010","volume":"63","author":"Ojodu J","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1089\/heq.2020.0127"},{"key":"e_1_2_9_24_1","volume-title":"Unequal treatment: confronting racial and ethnic disparities in health care","author":"Institute of Medicine (US","year":"2003"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.ss7109a1"},{"key":"e_1_2_9_26_1","unstructured":"Georgia Department of Public Health.Newborn Screening (NBS). Georgia Department of Public Health. 2022. Accessed September 26 2022.https:\/\/dph.georgia.gov\/NBS"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijns4040039"},{"key":"e_1_2_9_28_1","unstructured":"Centers for Disease Control and Prevention.Hemoglobinopathies: current practices for screening confirmation and follow\u2010up. December 2015. Accessed April 7 2024.https:\/\/www.cdc.gov\/ncbddd\/sicklecell\/documents\/nbs_hemoglobinopathy\u2010testing_122015.pdf"},{"key":"e_1_2_9_29_1","unstructured":"LanePA.Neonatal screening for sickle cell disease. January 9 2001. Accessed September 18 2023.https:\/\/sickle.bwh.harvard.edu\/screening.html"},{"key":"e_1_2_9_30_1","unstructured":"Georgia Department of Public Health.Georgia Newborn Screening Program policy and procedure manual. NBS Policies and Procedures. June 2015. Accessed April 7 2024.https:\/\/dph.georgia.gov\/NBS\/nbs\u2010policies\u2010and\u2010procedures"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.02.011"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood\u20102022\u2010156451"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/phh.0000000000000034"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6643a3"},{"key":"e_1_2_9_35_1","unstructured":"Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases.Vaccination coverage among young children (0\u201335 months). September 28 2020. Accessed April 7 2024.https:\/\/www.cdc.gov\/vaccines\/imz\u2010managers\/coverage\/childvaxview\/interactive\u2010reports\/index.html"},{"key":"e_1_2_9_36_1","unstructured":"GierkeR WodiAP KobayashiM Pneumococcal disease: epidemiology and prevention of vaccine\u2010preventable diseases. August 18 2021. Accessed March 25 2024.https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/pneumo.html"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.focus.2023.100158"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26390"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen\u20102022\u2010069075"},{"key":"e_1_2_9_40_1","unstructured":"Centers for Disease Control and Prevention.Pneumococcal vaccination: summary of who and when to vaccinate. vaccines and preventable diseases. April 14 2023. Accessed June 6 2023.https:\/\/www.cdc.gov\/vaccines\/vpd\/pneumo\/hcp\/who\u2010when\u2010to\u2010vaccinate.html"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24110"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007\u20100018"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1067\/S0022-3476(03)00331-7"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022009643"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.5863\/1551\u20106776\u201025.1.39"},{"key":"e_1_2_9_46_1","unstructured":"Mayo Clinic.Hydroxyurea (oral route) precautions. Mayo Clinic. April 1 2024. Accessed February 17 2023.https:\/\/www.mayoclinic.org\/drugs\u2010supplements\/hydroxyurea\u2010oral\u2010route\/precautions\/drg\u201020068109"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.11.002"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2013.11.003"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080901"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12388"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007\u20100538"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.4161\/hv.27243"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1745\u20107599.2009.00401.x"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.01.023"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29619"},{"key":"e_1_2_9_56_1","unstructured":"Rep. Lee B [D C 13]. H.R.8855 \u2010 117th Congress (2021\u20102022):Sickle Cell Disease Treatment Centers Act of 2022.; 2022. Accessed April 7 2024.https:\/\/www.congress.gov\/bill\/117th\u2010congress\/house\u2010bill\/8855\/all\u2010info"},{"key":"e_1_2_9_57_1","unstructured":"Health Resources & Services Administration.Newborn screening results and follow\u2010up. December 2023. Accessed April 7 2024.https:\/\/newbornscreening.hrsa.gov\/newborn\u2010screening\u2010process\/newborn\u2010screening\u2010results\u2010and\u2010follow"},{"key":"e_1_2_9_58_1","unstructured":"Health Resources & Services Administration.Sickle cell disease newborn screening follow\u2010up program. Accessed July 17 2023.https:\/\/www.hrsa.gov\/grants\/find\u2010funding\/HRSA\u201021\u2010036"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/NCM.0000000000000260"},{"key":"e_1_2_9_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.02.004"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31042","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/pbc.31042","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.31042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T14:23:19Z","timestamp":1773411799000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.31042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":59,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/pbc.31042"],"URL":"https:\/\/doi.org\/10.1002\/pbc.31042","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,3]]},"assertion":[{"value":"2023-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e31042"}}